Clofazimine

Records for this ingredient, by country (identity only).

ATC J04BA01 · 6 markets · 11 records

Clofazimine 6 markets · 11 records Forms
Filters
MarketGB 4CN 2FR 2US 1JP 1

GB 4 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

  • 50 mgcapsuleLampreneManufacturer: Special Order also in CN·FR·US
    +1Other 1 marketsJP
  • 100 mgcapsuleLampreneManufacturer: Special Order also in FR

CN 2 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 50 mgcapsuleManufacturer: 山西立业制药有限公司 ×2 also in GB·FR·US
    +1Other 1 marketsJP

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 50 mgcapsuleランプレンカプセル50mg also in GB·CN·FR
    +1Other 1 marketsUS

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.